MannKind shares, Friday focus on the U.S. listing

MannKind Corp shares close the week with a U.S. listing setup on Nasdaq. The stock trades in the U.S. market, and the article centers on Friday's sector context and the company's inhaled therapy business.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-26, 22:20.

MannKind Corp (US5638651064) ends Friday with its U.S. listing and sector context in view. The shares trade on Nasdaq, and Financial Times market data pointed to a mixed U.S. session on Friday.

U.S. market tone

Friday's tape was uneven, with FT market data noting that U.S. stocks were on track to break a losing streak despite falls in chipmakers. That keeps attention on U.S.-listed healthcare names such as MannKind, which trades in the same market structure.

The broader tone also matters for a mid-cap biotech and diabetes-focused company like MannKind, where liquidity, sector sentiment and U.S. risk appetite can influence day-to-day trading. Barchart's U.S. market overview also described a mixed finish for the session. Financial Times market data on U.S. equities

Analyst frame

For retail investors, consensus and analyst coverage matter as much as the tape on a Friday close. MarketScreener-style consensus pages are often used to track ratings and expectations, but the current article stays with the live market backdrop that is already visible in U.S. equity trading.

That backdrop is relevant for MannKind because the company competes in a crowded diabetes and respiratory-treatment field where peers trade on U.S. exchange sentiment as much as company-specific news. Barchart's overview of Friday's session gives the same mixed signal from the broader market. Barchart's Friday U.S. market overview

What MannKind sells

MannKind's core business centers on inhaled therapeutic products, including Afrezza, the company's inhaled insulin for adults with diabetes. The pipeline also includes assets tied to pulmonary and endocrine treatment, which keeps the model rooted in specialty healthcare.

Where the stock trades today

MannKind Corp shares last traded at 0.00 USD as of 2026-06-26 22:20 UTC, with the U.S. listing as the relevant venue for this article.

MannKind at a glance

• Company: MannKind Corp
• ISIN: US5638651064
• Ticker: MNKD
• Trading venue: Nasdaq
• Price (as of 2026-06-26 22:20): 0.00 USD
• Sector / industry: Health Care / Biotechnology
• Index membership: not officially confirmed
• Next earnings date: not officially scheduled

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.